TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 74 filers reported holding TRINITY BIOTECH PLC in Q4 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,261,000 | +24.0% | 171,001 | +6.4% | 0.17% | +17.4% |
Q2 2016 | $1,823,000 | +1.8% | 160,762 | +4.7% | 0.14% | -11.1% |
Q1 2016 | $1,791,000 | +6.3% | 153,555 | +7.2% | 0.16% | +6.6% |
Q4 2015 | $1,685,000 | -71.3% | 143,267 | -72.0% | 0.15% | -73.0% |
Q3 2015 | $5,862,000 | -19.5% | 512,463 | +27.1% | 0.56% | -16.3% |
Q2 2015 | $7,284,000 | -20.3% | 403,333 | -15.0% | 0.67% | -14.4% |
Q1 2015 | $9,138,000 | +101.9% | 474,722 | +83.7% | 0.79% | +54.4% |
Q4 2014 | $4,525,000 | +76.3% | 258,391 | +83.9% | 0.51% | +45.0% |
Q3 2014 | $2,567,000 | +17.4% | 140,530 | +48.1% | 0.35% | +13.2% |
Q2 2014 | $2,186,000 | +94.3% | 94,912 | +104.4% | 0.31% | +77.1% |
Q1 2014 | $1,125,000 | -16.5% | 46,431 | -13.4% | 0.18% | -15.5% |
Q4 2013 | $1,347,000 | +18.7% | 53,596 | +2.7% | 0.21% | +12.5% |
Q3 2013 | $1,135,000 | +27.7% | 52,170 | -1.1% | 0.18% | +17.2% |
Q2 2013 | $889,000 | – | 52,730 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
22NW, LP | 873,594 | $4,455,000 | 2.19% |
STONEHILL CAPITAL MANAGEMENT LLC | 738,829 | $3,768,000 | 1.54% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,026,624 | $5,236,000 | 1.43% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 711,185 | $3,627,000 | 1.34% |
Lapides Asset Management, LLC | 1,173,400 | $5,984,000 | 1.30% |
Adirondack Research & Management Inc. | 408,337 | $2,083,000 | 0.82% |
Paradice Investment Management LLC | 1,639,296 | $8,360,000 | 0.61% |
HEARTLAND ADVISORS INC | 1,346,150 | $6,865,000 | 0.44% |
Senvest Management, LLC | 1,003,988 | $5,120,000 | 0.36% |
Fondren Management LP | 100,000 | $510,000 | 0.36% |